Novartis Beats Patent Listing Suit Over Entresto
A New York federal judge gave Novartis permanent relief from a proposed class action alleging it monopolistically delayed generic competition for its blockbuster heart failure drug Entresto, concluding that the drugmaker...To view the full article, register now.
Already a subscriber? Click here to view full article